Decheng Capital Management III (Cayman), LLC - AURA BIOSCIENCES INC ownership

AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 74 filers reported holding AURA BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 2.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Decheng Capital Management III (Cayman), LLC ownership history of AURA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$18,243,928
+403.6%
1,163,123
+296.5%
6.09%
+436.0%
Q2 2023$3,622,663
+33.1%
293,3330.0%1.14%
+3.5%
Q1 2023$2,722,130
-11.6%
293,3330.0%1.10%
-4.8%
Q4 2022$3,079,997
-19.1%
293,333
+39.7%
1.15%
-16.4%
Q3 2022$3,805,000
+27.9%
210,0000.0%1.38%
+22.3%
Q2 2022$2,976,000
-35.6%
210,0000.0%1.13%
-20.3%
Q1 2022$4,620,000210,0001.42%
Other shareholders
AURA BIOSCIENCES INC shareholders Q2 2024
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,039,892$22,981,5846.86%
Decheng Capital LLC 515,555$3,897,5961.19%
Eventide Asset Management 5,802,682$43,868,2760.75%
Nantahala Capital Management 1,270,035$9,601,4650.56%
Matrix Capital Management Company, LP 6,922,870$52,336,8970.40%
Long Focus Capital Management, LLC 1,057,188$7,992,3410.31%
ADAR1 Capital Management, LLC 203,237$1,536,4720.29%
LEVIN CAPITAL STRATEGIES, L.P. 327,466$2,475,6430.26%
TBH Global Asset Management, LLC 60,322$456,0370.10%
Corton Capital Inc. 25,184$190,3910.10%
View complete list of AURA BIOSCIENCES INC shareholders